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Selective autophagy is a process whereby speciﬁc targeted cargo proteins, aggregates, or organelles are sequestered into double-
membrane-bound phagophores before fusion with the lysosome for protein degradation. It has been demonstrated that the
microtubule network is important for the formation and movement of autophagosomes. Nbr1 is a selective cargo receptor
that through its interaction with LC3 recruits ubiquitinated proteins for autophagic degradation. This study demonstrates an
interaction between the evolutionarily conserved FW domain of Nbr1 with the microtubule-associated protein MAP1B. Upon
autophagy induction, MAP1B localisation is focused into discrete vesicles with Nbr1. This colocalisation is dependent upon an
intact microtubule network as depolymerisation by nocodazole treatment abolishes starvation-induced MAP1B recruitment to
these vesicles. MAP1B is not recruited to autophagosomes for protein degradation as blockage of lysosomal acidiﬁcation does
not result in signiﬁcant increased MAP1B protein levels. However, the protein levels of phosphorylated MAP1B are signiﬁcantly
increaseduponblockageofautophagicdegradation.ThisistheﬁrstevidencethatlinkstheubiquitinreceptorNbr1,whichshuttles
ubiquitinated proteins to be degraded by autophagy, to the microtubule network.
1.Introduction
Cellular turnover of damaged and misfolded proteins is
mediated by two main degradation pathways; macroau-
tophagy (hereafter referred to as autophagy) and the ubiq-
uitin proteasome system (UPS). The UPS targets solu-
ble, cytosolic proteins to the proteasome where they are
degraded. Proteins targeted for degradation are covalently
modiﬁed by the small, highly conserved, ubiquitously ex-
pressed protein ubiquitin. Ubiquitin can form chains at all
seven lysine residues and typically, chains of four or more
ubiquitin molecules are required for the targeting of proteins
to the proteasome [1]. However, misfolded proteins can
form large aggregates which render them resistant to pro-
teasomal degradation [2]. Autophagy is an evolutionary
conserved catabolic process that serves to deliver large
polyubiquitinatedproteinaggregatesandwholeorganellesto
the lysosome for degradation [3]. A block in this process can
cause the accumulation of ubiquitinated protein aggregates
and ultimately cell death [4].
Autophagy requires the coordinated action of 35 to date
autophagy-related genes (ATG) that mediate the formation
of the double-membrane bound autophagosome which
encloses a portion of the cytoplasm and delivers it to
the lysosome [5, 6]. There are two ubiquitin-like conju-
gation systems that are required for autophagosomal for-
mation. The Atg12-Atg5-Atg16L complex is important for
elongation of the isolation membrane [7] whilst Atg8/LC3,
covalently attached to phosphatidylethanolamine (PE) is
essentialforautophagosomebiogenesis[8].LC3isoftenused2 International Journal of Cell Biology
as a marker for autophagosomes and has been shown to
bind and stabilise microtubules [9, 10]. The microtubule
network is important for autophagosomal formation [11,
12]; however, its requirement for fusion of autophagosomes
with lysosomes is still unclear [11–13]. Roles for dis-
tinct populations of microtubules have also been proposed
whereby labile microtubules speciﬁcally recruit markers of
the isolation membrane such as Atg5, Atg12, and LC3 to sites
of autophagosomal formation whereas stable microtubules
facilitate the movement of mature autophagosomes [14].
Recent evidence demonstrates that autophagy can be a
selective process, whereby single proteins and cellular struc-
t u r e ss u c ha sa g g r e g a t e sa n do r g a n e l l e sc a nb es p e c i ﬁ c a l l y
targeted to autophagosomes [15, 16], but the molecular
mechanism of cargo recognition is poorly understood.
Recently autophagic receptors have been described which
include the structurally similar proteins p62 and NBR1, as
well as the TBK1 adaptor NDP52 [17–19]. These receptors
are thought to bind to polyubiquitinated proteins via their
C-terminal-ubiquitin-associated (UBA/UBZ) domains and
sort them to sites of autophagosomal formation via their
interaction with LC3 [20, 21]. Both NBR1 and p62 colocalise
with ubiquitin in Mallory bodies in the liver of patients with
alcoholic steatohepatitis [18] and accumulate with ubiquitin
in muscle ﬁbres of sporadic inclusion-body myositis [22].
In contrast to p62, NBR1 has not been extensively studied,
however growing evidence has implicated it in a diverse
range of biological functions. NBR1 interacts with the giant
sarcomeric protein titin and is part of a signalling complex
that regulates muscle gene expression [23]. A genetically
modiﬁed mouse model expressing a C-terminally truncated
form of Nbr1 identiﬁed a role for Nbr1 in bone remodelling
whilst a T-cell-speciﬁc knock-out of full length Nbr1 has
implicated NBR1 as a mediator of T-cell diﬀerentiation
and allergic inﬂammation [24, 25]. NBR1 has also recently
been shown to direct autophagic degradation of mid-
body derivatives, independent of p62 [26]. Additionally,
NBR1 inhibits receptor tyrosine kinase (RTK) degradation
by trapping the receptor at the cell surface [27]a n d
via its interaction with SPRED2, mediates the lysosomal
degradation of activated receptors and the attenuation of
ﬁbroblast growth factor (FGF) signalling [28]. Identiﬁcation
of other protein interactors of NBR1 such as calcium- and
integrin-binding protein (CIB) and fasciculation and elon-
gation protein zeta-1 (FEZ1) [29] have suggested additional
roles for NBR1 in cardiac dysfunction [30] and neuronal
development, respectively [31]. It has been shown that both
NBR1 and p62 are recruited to autophagosomal formation
sites independent of LC3; however, the mechanism is unclear
[32].
In this paper, we identify NBR1 as an interaction partner
of the microtubule-associated protein MAP1B. This occurs
via the evolutionarily conserved FW domain. We show that
whilst MAP1B is not itself a substrate for autophagosomal
protein degradation, the phosphorylated form of MAP1B
is stabilised by lysosomal inhibition. We propose that this
interactionprovidesamechanismbywhichNBR1istargeted
to the microtubule network to promote degradation of
proteins via the autophagosome.
2.MaterialsandMethods
2.1. Bioinformatics. BioEdit was used to curate sequences
and compile alignments. BLAST was used on various
databases to identify FW-like sequences from animal, plant,
fungal, protist, bacterial, and metagenome sequences. Phyre
was used for structural predictions.
2.2. Primary Antibodies and Constructs. For western blot
analysis and immunoﬂuorescence the following antibodies
were used: polyclonal anti-myc (A14, Santa Cruz), mo-
noclonal anti-HA (Roche), monoclonal anti-myc (9E10,
Santa Cruz), and polyclonal anti-MAP1B-HC (kindly pro-
vided by Prof. Gordon-Weeks, King’s College London
[33, 34], polyclonal anti-MAP1B (N19, Santa Cruz), poly-
clonal anti-MAP1B (C20, Santa Cruz), polyclonal anti-
pThr1265-MAP1B (Novus Biologicals), monoclonal anti-
Nbr1 (Abcam), monoclonal anti-p62 (Abnova), and poly-
clonal anti-p62 (kindly provided by Prof. Gautel, King’s
College London), polyclonal anti-ULK1 (Sigma), polyclonal
anti-ubiquitin (Dako), polyclonal anti-EEA1 (Cell Signal-
ing), polyclonal anti β-actin (Abcam), and monoclonal anti-
His (Novagen).
Yeast two-hybrid bait for Nbr1 was ampliﬁed by PCR
and cloned into pGBKT7 (Nbr1 aa346-498) (Clontech). Full
length Nbr1 was cloned into pHM6 (Roche) and MAP1B
aa2216- 2464 was cloned into pcDNA3.1 (Invitrogen) for the
coimmunoprecipitation assay. Nbr1 aa346-498 was cloned
intopGEX2T(GEHealthcare)fortheGST-bindingassayand
MAP1B aa2227-2464 was cloned into PET6H (a modiﬁed
version of pET11d-Novagen) for the recombinant binding
assay.
2.3. Yeast-2-Hybrid. Yeast strain Y187 was transformed with
the Nbr1 bait construct and mated with a pretransformed
(yeast strain AH109) mouse neonatal calvarial cDNA library
kindly supplied by Prof. Ikramuddin Aukhil, University
of Florida. Resulting colonies were screened by HIS3
reporter gene activity, replated three times and inserts were
sequenced.Y187transformedwithpGBKT7Nbr1aa346-498
was mated with yeast strain AH109 expressing the library
MAP1B clone pGADT7 MAP1B aa2238-2465 and plated
onto SD medium lacking leucine, tryptophan, histidine and
adenine and were cultured at 30◦C to verify the interaction.
2.4. Coimmunoprecipitation. COS7 cells were cotransfected
with HA-Nbr1 and MAP1B-myc and after 48 hours, lysed
in IP buﬀer (50mM Tris pH 7.5, 150mM NaCl, 0.5% NP-
40, supplemented with protease and phosphatase inhibitors
(Roche)), and cell lysates incubated with rabbit polyclonal
anti-myc antibody overnight at 4◦C. Protein A beads (Mil-
lipore) were then added to the lysates for a further 2
hours, beads were then washed three times in IP buﬀer.
Proteins retained on the beads were separated by SDS-
PAGE and transferred onto a nitrocellulose membrane
following standard procedures. Blots were probed with
mouse monoclonal anti-myc and rat monoclonal anti-HA
antibodies and subsequently with a secondary antibodyInternational Journal of Cell Biology 3
(HRP-conjugated anti-mouse or anti-rat, Dako, Abcam).
Detection was performed by ECL (GE Healthcare).
2.5. Bacterial Expression of Fusion Proteins. Nbr1 aa346-498
fused to GST and GST alone were expressed in Bl21(DE3)
bacterial cells and proteins puriﬁed by glutathione aﬃn-
ity chromatography as previously described [35]. MAP1B
aa2227-2464 fused to His6 was also expressed in Bl21(DE3)
bacterial cells and puriﬁed in the presence of urea. Brieﬂy,
bacterial cells expressing His6-MAP1B aa2227-2464 were
lysed in lysis buﬀer (100mM NaH2PO4,1 0m MT r i sp H8 ,
6M Urea, 5mM Imidazole pH 8, supplemented with EDTA-
free protease inhibitors (Roche)). The sample was sonicated,
centrifuged, and the supernatant was incubated with Ni
Sepharose 6 fast ﬂow beads (Amersham Biosciences) for 2
h o u r sa t4 ◦C. Beads were then washed in low Imidazole
elution buﬀer (100mM NaH2PO4,1 0 m MT r i sp H8 ,6 M
Urea, 20mM Imidazole pH 8, supplemented with EDTA
free protease inhibitors (Roche)) and bound proteins eluted
from the beads using high Imidazole elution buﬀer (100mM
NaH2PO4,1 0m MT r i sp H8 ,6MU r e a ,2 5 0m MI m i d a z o l e
pH 8, supplemented with EDTA-free protease inhibitors
(Roche)). The resulting puriﬁed His-tagged protein was
dialysed into 50mM Tris pH 7.5, 150mM NaCl and used in
the GST pull-down assay.
2.6.GSTPull-DownAssays. COS7cellsweretransfectedwith
a MAP1B-myc construct and after 48 hours expression, lysed
in IP buﬀer (as above), and lysates incubated with beads
coupled with either GST-Nbr1 aa346-498 or GST alone for 2
hoursat4◦C.Followingincubation,beadswerewashedthree
times in IP wash buﬀer (50mM Tris pH 7.5, 200mM NaCl,
0.5% NP-40, supplemented with protease and phosphatase
inhibitors (Roche)) and proteins retained on the beads were
analysed by western blotting as described above, using the
monoclonal anti-myc antibody, 9E10. Alternatively puriﬁed
GSTorGST-Nbr1aa346-498attachedtoglutathioneagarose
beads (Sigma) was incubated in IP buﬀer (50mM Tris
pH 7.5, 150mM NaCl, 0.5% NP-40, supplemented with
protease and phosphatase inhibitors (Roche)) with puriﬁed
His6-MAP1B aa2227-2464 for 2 hours at 4◦C. Following
incubation, beads were washed three times in IP wash buﬀer
(50mM Tris pH 7.5, 200mM NaCl, 0.5% NP-40), and
proteins retained on the beads were separated by SDS-PAGE
and analysed by western blotting as described above, using
the anti-His tag monoclonal antibody.
2.7. Cell Culture, Treatments, Transfection and Immunos-
taining. C O S 7c e l l sw e r ec u l t u r e di nD M E M / 1 0 %F C Sb y
standard protocols and transfected using Fugene 6 (Roche).
C e l l sw e r el y s e d4 8h o u r sl a t e ri n2 0 0μLI Pb u ﬀer for pull-
downandcoimmunoprecipitationassays.Forimmunostain-
ing PC12 cells were cultured on coverslips in DMEM/10%
FCS, treated with DMSO or Baﬁlomycin A1 (Sigma) for 4 or
8 hours, or starved in Hanks-Balanced Salt Solution (Sigma)
for 4 hours or treated with 5μg/mL nocodazole (Sigma)
for 30 minutes before or after 2 hours starvation and ﬁxed
in 4% paraformaldehyde/PBS for 10 minutes. Cells were
then permeabilised in 0.1% Triton X100/PBS and incubated
consecutivelywithprimaryandsecondaryantibodies(Dako)
for one hour each prior to mounting. Cells were imaged
using a Zeiss LSM 510 confocal microscope in sequential
scanning mode with a Plan-Apochromat 63x/1.4 Oil DIC
objective. Quantiﬁcation of MAP1B/Nbr1 colocalisation was
performed using Zeiss ZEN2010 software, data represent
mean±SEM of 22 images.
3. Results
3.1. The Predicted Structure and Evolution of Nbr1 FW
Domain. We used BLAST-based searches to acquire NBR1-
related sequences from multiple available genomic and tran-
scriptomic sources across a broad range of eukaryotes.
These identiﬁed a region of pronounced conservation of 105
amino acids (residues 374–478 of human NBR1) which is
recognisable in the single NBR1 orthologue found in most
eukaryotes but is absent from p62. This novel domain has
been named the NBR1 domain [36] and FW domain by
Terje Johansen’s group [37] after its four strikingly conserved
tryptophan residues, and we will use FW nomenclature here
for clarity.
Single NBR1 orthologues were found in all animals,
most plants, most fungi (though notably not Saccharomyces
cerevisiae) and some single-celled eukaryotes (such as Dic-
tyostelium discoideum). In each case the NBR1-like molecule
possessed an N-terminal PB1 domain, one (animals, plants)
or more (fungi) ZZ domains, an FW domain, and a C-
terminal UBA domain (Figure 1).
The FW domain was also found in a second, otherwise
unrelated animal protein. As the human version has been
named c6ORF106, we will use this name. Single c6ORF106
orthologues are found in all animal species examined, plus
the single-celled metazoan sister-group choanoﬂagellates.
No c6ORF106 orthologues were found in any other organ-
isms. The proteins tend to be small (the human c6ORF106
is 298 amino acids long), comprising a universally conserved
N-terminal α-helical domain of ∼70–80 amino acids, then
the FW domain and ﬁnally a poorly structured and variable
length C-terminal region (Figure 1).
Intriguingly, FW domains were also found in a wide
range of eubacteria. The eubacterial FW-containing proteins
are strikingly diverse in domain structure, with the only
common theme being that the FW domain tends to be very
close to the C-terminus. Although most eubacterial geno-
mes do not encode an FW domain-containing protein, we
ﬁnd that it is broadly distributed across eubacterial clades
(γ-proteobacteria, chloroﬂexi, actinobacteria, and several
unclassiﬁed metagenomes). In several of the bacterial pro-
teins (Halorhodospira halophila, Methylomonas methanica,
Kribbella ﬂavida, Variovorax paradoxus, and one from a fresh
water environmental metagenome), the FW domain appears
immediately C-terminal to a robustly predicted “helix-turn-
helix” DNA-binding motif of the XRE family. We call these
XRE-FW proteins. XRE domains tend to appear either alone
or with multimerisation domains (as in the Bacillus subtilis
repressor of sporulation and bioﬁlm formation, SinR and4 International Journal of Cell Biology
ZZ domain
UBA domain
3-helical domain (UBA-like?)
Coiled coil region
Domain shared between NBR1, c6ORF106, and bacterial TFs
Human NBR1
Human p62
Human c6ORF106
Fish NBR1
Fish p62
Fish c6ORF106
Anemone NBR1
Anemone p62
Anemone c6ORF106
Arabidopsis NBR1
Aspergillus NBR1
Halorhodospira
Plants
Fungi
Bacteria
Animals
PB1
PB1
PB1
PB1
PB1
PB1
PB1
PB1
ZZ
ZZ
CC CC
ZZ
ZZ
ZZ
CC
CC CC
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
UBA
UBA
UBA
UBA
ZZ
ZZ
ZZ ZZ ZZ ZZ
UBA
UBA UBA
UBA
UBA
HLH
PB1 domain Other patches of conservation
Figure 1: Schematic representation of the commonest members of the FW-containing protein families- the NBR1 proteins found in almost
all eukaryotes, the c6ORF106 proteins found in almost all metazoans and the XRE-FW proteins found in some bacteria. The metazoan p62
family is also included to show its relationship to NBR1. Proteins are drawn to scale. A key to the domains appears at the bottom of the
ﬁgure.
the bacteriophage repressors CI and Cro). This juxtaposition
raises the possibility that the FW domain might mediate
homo- and/or heterodimerisation or could bind a small
signalling molecule. Some other eubacterial FW proteins
consist solely of two tandem FW domains and little else (e.g.,
thatfromCoprococcus),whileotherscontaintransmembrane
domains (e.g., that from Streptomyces sp.). This structural
diversitysuggeststhattheFWdomainhasagenericallyuseful
function that has been exploited in many ways.
We used Phyre to predict the secondary structure of all
FW domains separately. This robustly predicted the same
alignable structural features in every sequence, regardless
of sequence divergence (Figure 2). Thus we feel that we
are able to say with some conﬁdence that the FW domain
consists of two sets of three β-strands separated by a
central unstructured region of more variable length. Striking
sequence features include four almost invariant tryptophan
residues, which lie in the middle of strand β2, in the linker
between β2a n dβ3, and in the middle of strands β5a n dβ6.
These give the domain its name and are only rarely replaced
by other aromatic residues. There are also several invariant
glycines and prolines in some of the unstructured linkers. It
is conceivable that the domain folds into a sandwich of two
three-strand β-sheets with the tryptophans projecting into
the hydrophobic core.
Phylogenetic analysis showed that all NBR1 FW domains
clustered together, as did all c6ORF106 FW domains. Two
FW sequences from metagenomic sources clustered with
NBR1 sequences; one of these had a C-terminal UBA do-
main, and we assume that these are from eukaryotic species
intheenvironmentalmetagenomesources.Thereproducible
monophyletic clustering of bacterial FW domains (to the
exclusion of eukaryotic NBR1 and c6ORF106 sequences)
argues against multiple eukaryote-to-prokaryote horizontal
gene transfer events and suggests that the FW domain
may be ancient, predating the split between eukaryotic and
eubacterial domains.
3.2. Identiﬁcation of the FW Domain of Nbr1 as an Interac-
tion Partner of Microtubule-Associated Protein MAP1B. To
identify novel protein interactors of the highly conserved
FW domain of Nbr1 and therefore elucidate a function, we
performed a yeast-2-hybrid screen with the FW domain of
Nbr1 as bait. A neonatal calvarial cDNA library was screened
and the light chain of the microtubule-associated protein
1B (MAP1B-LC1) was identiﬁed as an interaction partner
of Nbr1. This interaction was veriﬁed by a directed yeast
two-hybrid assay by retransforming the isolated prey vector
encoding the partial MAP1B-LC1 sequence (aa2238-2465)International Journal of Cell Biology 5
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adhaerens;C h o a n o — Monosiga brevicollis;M y c o b a c — Mycobacterium sp. MCS; Halorho—Halorhodospira halophila; FrMeta—Fresh water
metagenome; MarMeta—Marine metagenome; MatMeta—Mat metagenome; Herpeto—Herpetosiphon sp.
into yeast strain AH109 and mating it with yeast strain Y187
that was expressing the FW domain of Nbr1 (Figure 3(a)).
MAP1B is transcribed as a single mRNA, translated into a
polypeptide, and subsequently cleaved producing a heavy
chain (2214aa) and a light chain (250aa) [38]. Both the
heavy chain (MAP1B HC) and the light chain (MAP1B-LC1)
can bind to microtubules [39, 40] and to each other [41].
MAP1B has been implicated in the regulation of autophagy,
as it interacts with LC3 and targets autophagosomes to axon
terminals during neurodegeneration [42].
3.3. Nbr1 is Found in a Complex with MAP1B-LC1 In
Vivo. To determine whether Nbr1 forms a complex with
MAP1B-LC1 in vivo, we performed a coimmunoprecipi-
tation experiment using COS7 cells transiently transfected
with HA-Nbr1 and MAP1B-LC1-myc constructs. Using an
anti-myc antibody for immunoprecipitation of MAP1B-
LC1-myc, we found that HA-Nbr1 did coimmunoprecipitate
with MAP1B-LC1-myc (Figure 3(b)) conﬁrming that they
are found in a complex in vivo.W ew e r eu n a b l et os h o w
coimmunoprecipitation of endogenous Nbr1 and MAP1B-
LC1 in PC12 cells. This is likely to be due to the levels of
interacting protein being below the detection level possible
by western blot analysis with the available antibodies (data
not shown).
3.4. Nbr1 Interacts with MAP1B-LC1 In Vitro. The yeast-
2-hybrid data suggested that the FW domain of Nbr1
interacts directly with MAP1B-LC1. To more rigorously test
this hypothesis, we performed GST pull-down assays using
extracts from COS7 cells overexpressing MAP1B-LC1-myc
and a GST fusion of the FW domain of Nbr1 and GST alone.
Indeed, the FW domain of Nbr1 interacted with MAP1B-
LC1 whilst GST alone did not (Figure 4(a)).
ToverifytheinteractionbetweentheFWdomainofNbr1
and MAP1B-LC1 in a cell-free environment, His6-MAP1B-
LC1 was puriﬁed and incubated with the GST fusions of the
FW domain of Nbr1 or GST alone. This demonstrated that
theFWdomainofNbr1interactsdirectlywiththelightchain
of MAP1B (Figure 4(b)).
3.5. MAP1B Is Not Degraded by Autophagy. It has previ-
ously been observed that MAP1B-HC is not degraded by
autophagy [42] however, it has not been reported whether
the same is true for MAP1B-LC1. To establish if the function
of the interaction between Nbr1 and MAP1B-LC1 is to
facilitate the degradation of MAP1B-LC1 via autophagy,
MAP1B-LC1 protein levels were analysed under conditions
where autophagic protein degradation was blocked. PC12
cells, a neuronal cell line that expresses elevated levels of
endogenous MAP1B, were treated with Baﬁlomycin A1 or
DMSO for 8 hours before protein extracts were resolved
by SDS PAGE and detected using antibodies that recognise
p62, Nbr1, MAP1B-LC1, MAP1B-HC and β-actin. Upon
blockage of autophagic protein turnover, the levels of p62
and Nbr1 were increased by 60% and 130%, respectively,
demonstrating that autophagic protein degradation was
blocked by Baﬁlomycin A1 treatment (Figures 5(a) and
5(b)). MAP1B-HC, and MAP1B-LC1 protein levels showed
a negligible increase upon the blockage of autophagic
protein degradation suggesting that they are not degraded
by autophagy and that the function of the Nbr1-MAP1B-
LC1 interaction is not to target MAP1B-LC1 for autophagic
protein turnover. Surprisingly, although total MAP1B levels6 International Journal of Cell Biology
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are largely unaﬀected by blocking autophagic protein degra-
dation, levels of phospho-pThr1265-MAP1B are increased
following Baﬁlomycin A1 treatment (Figure 5(c)). This
phosphorylated form of MAP1B is expressed in diﬀerenti-
ating neurons and is a major substrate for glycogen synthase
kinase-3beta (GSK-3beta) and is thought to be involved in
regulating microtubule dynamics by MAP1B [43].
3.6. Nbr1 Colocalises with MAP1B upon Induction of Au-
tophagy. Next, we analysed the subcellular localisation of
endogenous Nbr1 and MAP1B by confocal microscopy.
To establish if Nbr1 and MAP1B colocalise in vivo,P C 1 2
cells were treated with DMSO, Baﬁlomycin A1 to block
autophagic protein degradation or starved to induce auto-
phagy and analysed by immunoﬂuorescence. Under basal
conditions, when levels of Nbr1 are low, there was little
colocalisation between Nbr1 and MAP1B (Figure 6(A)).
Upon blockage of autolysosomal protein degradation by
Baﬁlomycin A1 treatment, Nbr1 is no longer turned over
by autophagy and accumulates (Figure 6(B)) but total
MAP1B is unaﬀected and appears excluded from Nbr1-
positive vesicles. This conﬁrms that MAP1B is not itself
degraded by the autolysosomal pathway. Upon starvation
and induction of autophagy, Nbr1 and MAP1B colocalise
to distinct perinuclear vesicular structures (Figure 6(C)).
Although this does not occur in all cells, only under
starvation conditions were MAP1B-/Nbr1-positive vesicles
observed. Under starvation conditions where MAP1B/Nbr1
positive punctate structures were observed, quantiﬁcation of
colocalisation showed a Mander’s colocalisation coeﬃcient
of 64 ± 10%. These MAP1B-/Nbr1-positive vesicles also
colocalise with the autophagic protein p62 (Figure 6(D)) but
few colocalise with ubiquitin, suggesting that these vesiclesInternational Journal of Cell Biology 7
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Figure 5: Western blot analysis of p62, Nbr1, MAP1B-HC, and MAP1B-LC1 protein levels following blockage of autophagic protein
degradation. (a) Western blots showing protein levels in cells treated with DMSO (control) or Baﬁlomycin A1 (Baf). (b) Quantiﬁcation
of protein band intensity. MAP1B-LC1 and MAP1B-HC levels are increased by a negligable amount compared with Nbr1 and p62 upon
treatment with Baﬁlomycin A1; Error bars represent SD, n = 3. (c) Phospho-MAP1B-HC is degraded by autophagy. Upon blockage of
autophagic degradation with Baﬁlomycin A1: (Baf), levels of phospho-MAP1B-HC increase compared with levels of total MAP1B-HC.
are not aggresomes or mature autophagosomes loaded with
ubiquitinated cargo (Figure 6(F)). We found little overlap-
ping distribution with ULK1 and Nbr1/MAP1B vesicles
under starvation conditions, in comparison with previous
analysis of Nbr1/ULK1 colocalisation under these conditions
[32]( Figure 6(E)) or with the early endosomal marker EEA1
(Figure 6(G)). This demonstrates that upon induction of
autophagy, Nbr1 is recruited to MAP1B positive structures
which are colocalising with p62, suggesting these may be
early autophagosomes but downstream of autophagosomal
formation sites.
To determine if colocalisation of Nbr1 and MAP1B in
response to starvation-induced autophagy was dependent
upon an intact microtubule network, PC12 cells were treated
with the depolymerisation agent nocodazole under starva-
tion conditions and examined for colocalisation. Depoly-
merisation of the microtubule network was conﬁrmed by
α-tubulin staining (data not shown) and resulted in loss of
the punctate colocalisation of MAP1B and Nbr1 but intact
Nbr1 vesicles were retained (Figure 6(H)). This suggests that
MAP1B is not essential for the formation of Nbr1-positive
vesicles but that an intact microtubule network is essential
for colocalisation of Nbr1 and MAP1B under starvation
conditions.
4. Discussion
The FW domain of Nbr1 is highly conserved throughout
the eukaryotic kingdom and is also present in a number of
bacterial proteins. It contains two internal repeats of ∼55
residues and has a predicted secondary structure consisting
of two, three β-stranded sheets. The high conservation of
this region and its absence in p62 [37] suggests that it has a
function that is distinct from p62. We therefore performed a
yeast-2-hybrid screen with the FW domain of Nbr1 in order
to determine a speciﬁc function for this region. The light
chain of MAP1B (MAP1B-LC1) was identiﬁed as an inter-
action partner of the FW domain. As Nbr1 has previously
been identiﬁed as an autophagic receptor that targets ubiqui-
tinated proteins for degradation via its interaction with LC3
[18, 19], it was reasonable to hypothesise that the function of
theinteractionbetweenNbr1andMAP1B-LC1istofacilitate
the autophagic degradation of MAP1B-LC1. Analysis of
protein levels after autophagy blockage demonstrated that
the levels of MAP1B-LC1 increased by a negligible amount
suggesting that it is not degraded by autophagy (Figure 5).
Blockage of autophagosomal protein degradation can also
result in a reduction of protein turnover by the UPS [44]
therefore, as MAP1B-LC1 is known to be degraded by the8 International Journal of Cell Biology
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Figure 6: Nbr1 and MAP1B colocalise in discrete perinuclear vesicles upon induction of autophagy. PC12 cells were treated with DMSO,
Baﬁlomycin or starved then ﬁxed and stained with antibodies against the indicated proteins. Under basal conditions (A) or when autophagic
degradation is blocked by Baﬁlomycin A1 treatment (B), very little or no colocalisation was observed between Nbr1 and MAP1B. When
cells were starved to induce autophagy (C) MAP1B and Nbr1 colocalise in distinct perinuclear vesicles which are also positive for p62 (D)
but are largely negative for ULK1 (E), ubiquitin (F), and EEA1 (G). Upon depolymerisation of the microtubule network and subsequent
induction of autophagy by starvation, MAP1B no longer colocalised in distinct perinuclear vesicles with Nbr1 (H). Antibodies used: anti-
Nbr1 (abcam), anti-MAP1B (N19, Santa Cruz), anti-p62 (M. Gautel, KCL), anti-ULKl (Sigma), anti-ubiquitin (Ub) (Sigma), and anti-EEAl
(Cell Signaling). Scale bar; 10μm.
UPS [45], this could suggest that Baﬁlomycin A1 treatment
results in the inhibition of MAP1B-LC1 degradation via
the proteasome rather than by autophagy. Interestingly,
we observed that inhibition of autophagic degradation re-
sulted in an increase in phospho-Thr1265 MAP1B, perhaps
also reﬂected in the small increase in total MAP1B levels
observed. Expression of this phosphorylated form of MAP1B
is spatially regulated in diﬀerentiating neurons, and the
kinase responsible for phosphorylation at this site has been
identiﬁed as glycogen synthase kinase-3 beta. GSK-3 betaInternational Journal of Cell Biology 9
inhibition has been linked to Bif-1-dependent autophagic
induction under serum starvation to modulate cell survival
[46].
Further biochemical analysis conﬁrmed that the inter-
action between Nbr1 and MAP1B-LC1 is direct and that
these proteins can be found in a complex together in vivo. As
bothNbr1andthemicrotubulenetworkhavebeenidentiﬁed
as key players in the facilitation of protein degradation
via autophagy [11, 12, 18, 19], this could suggest that the
Nbr1-MAP1B-LC1 interaction is important for this process.
MAP1B interacts with LC3 and through this interaction
it has been proposed that autophagosomes are targeted to
axon terminals during neurodegeneration [47]. Additionally
MAP1B has been predicted to interact with Atg12 and Atg3
suggesting that in addition to LC3, MAP1B is important
for targeting other components of the autophagosomal
machinery to sites of autophagosomal formation [48]. The
interaction data presented here and the colocalisation of
Nbr1 and MAP1B to perinuclear vesicles suggest that via its
interactionwithMAP1B,Nbr1istargetedtothemicrotubule
network, thus providing a mechanism by which proteins can
be targeted to autophagosomes. The MAP1B-/Nbr1-positive
vesicles do not however colocalise with ubiquitin, suggesting
that these vesicles are not yet loaded with ubiquitinated
cargo.Alternatively,theycouldrepresentvesiclesloadedwith
other nonubiquitinated proteins that have been targeted for
degradation. Whilst there are currently no known proteins
that are targeted for autophagy by Nbr1 in a ubiquitin-
independent manner, STAT5A-ΔE18 can be targeted for
autophagic degradation by the PB1 domain of p62 inde-
pendent of ubiquitin [49]. This suggests that Nbr1 could
also be acting by a similar mechanism to target proteins for
degradationindependentofubiquitin.Nbr1/MAP1Bvesicles
didnotcolocalisewithEEA1,showingthatthesearenotearly
endosomes. Likewise, we saw largely no colocalisation of
MAP1B/Nbr1 vesicles with ULK1, suggesting that MAP1B-
and Nbr1-positive structures are not present at sites of
autophagosomal formation but do perhaps represent early
autophagosomes that are positive for p62 and nonubiquiti-
nated protein cargo.
This is the ﬁrst evidence linking Nbr1 to the micro-
tubule network and also demonstrates a distinct function
for the FW domain of Nbr1. A similar mechanism has
previously been demonstrated whereby HDAC6 is able to
interact with polyubiquitinated protein aggregates and to
dynein motors thereby coupling protein aggregates to the
microtubule network where they can be transported to sites
of autophagosomal formation [50]. Furthermore, adaptor
proteins such as FYCO can interact with LC3 and micro-
tubule motor proteins and through these interactions it
has been suggested that preautophagosomal membranes
are targeted to sites of autophagosomal formation [51].
Roles for MAP1S (a MAP1B homologue) in autophagic
degradation of mitochondria have also been demonstrated.
MAP1S interacts with LC3 and this interaction functions to
target LC3, to the microtubule network. Genetic ablation of
MAP1S causes the accumulation of defective mitochondria
and severe defects in response to nutritive stress suggesting
defects in autophagosomal biogenesis and clearance [52].
It has been suggested that recruitment of autophagosomal
cargo receptors like Nbr1 and p62 to the autophagosomal
formation site may be a general feature of this type of
receptor, but that it is independent of Atg factors down-
stream of the PI3-kinase complex [32]. This study further
highlights the role for microtubule associated proteins in the
targeting of autophagosome machinery to the microtubule
network and complements the work presented here that
suggests a link between microtubule-associated proteins and
autophagic receptors.
The high evolutionary conservation of the FW domain
within Nbr1 homologues implicates it to have a critical
role in Nbr1 function. The predicted secondary structure
of the FW domain that consists of two three β-stranded
sheets that form a compact “sandwich” is also present in
the cholesterol-binding protein Niemann-Pick C2 (NPC2)
[53, 54] suggesting additional roles for the FW domain in
lipid binding.
In summary, we present the ﬁrst evidence linking the
autophagic receptor protein Nbr1 and the microtubule net-
work via a direct interaction of the evolutionary-conserved
FW domain of Nbr1 with MAP1B. Nbr1 is a ubiquitously
expressed protein that has been implicated in several diseases
[18, 22, 23], and it therefore will be of signiﬁcant value to
assess this interaction in tissue-speciﬁc physiological studies.
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